Dr. Feng – PhD BioHealth Commercialization Plan and SBIR Grant Writer
Dr. Feng is a highly successful small business innovation grant writer, commercialization plan expert, and 12+ years former principal investigator of SBIR/STTR I and II grant awards. Lately, within a 12 month period, he helped with a number of grant submissions; among these, totaling >$10 million were selected for funding, including awards from the State, NSF and NIH SBIR/STTR Phase I, II and Fast Track programs. Dr. Feng regularly serves as a reviewer for the NSF and NIH SBIR/STTR panels as well as a mentor for local SBIR support programs. He has strong expertise in peer review of grants and was a former federal designated Scientific Review Officer of NIH responsible reviews of small business grant proposal and other types of grants such as R01, U54, and fellowships. He was an entrepreneur, CEO, and co-founder of several biotech companies that conducted innovative R&D, manufacturing, and product distribution worldwide. Dr. Feng enjoys mentoring and supporting early stage BioHealth science companies whose products and services range broadly, e.g. therapeutic discovery and development, stem cell technologies, tissue engineering, gene expression and gene therapy, surgical device, non-invasive imaging, point-of-care clinical diagnostic device, trans-omics, electronic health record, mobile health, health informatics, nanotechnologies, and environmental monitoring. Dr. Feng completed his B.S. in medicinal chemistry at the Peking University, China and Ph.D. in Biochemistry, Biophysics, and Molecular Biology at the University of Minnesota, Twin Cities. He obtained postdoc training at Harvard Medical School and Massachusetts Institute of Technology with a National Research Service Award from the NIH. Dr. Feng is highly qualified for grant writing, critique analysis, and preparing Commercialization Plans.
To work with Commercialization Plan Expert and SBIR Grant Writer Dr. Feng, please visit our quote page and request him in the description area.